Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $97.3500 (-0.94%) ($95.9000 - $100.0500) on Fri. Oct. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.32% (three month average) | RSI | 46 | Latest Price | $97.3500(-0.94%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND advances 1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(50%) IWM(48%) IWC(47%) | Factors Impacting LGND price | LGND will decline at least -1.16% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IGOV(-7%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.16% (StdDev 2.32%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $96.51(0.87%) | 10 Day Moving Average | $94.84(2.65%) | 20 Day Moving Average | $96.09(1.31%) | To recent high | -23.2% | To recent low | 8.7% | Market Cap | $1.565b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |